Bruker

Bruker revolutionized microbiology by its leading MALDI-TOF system for microbial identification. The MALDI Biotyper® sirius System, with the MBT Sepsityper® solution, allows direct identification from positive blood cultures and resistance testing. The IR Biotyper® enables rapid and easy strain typing for hospital hygiene and epidemiological studies. Bruker’s MICRONAUT and UMIC portfolios focus on antimicrobial susceptibility testing. The Molecular Diagnostics (MDx) offering includes an integrated sample-to-result workflow, and assays for the detection of mycobacteria (incl. TB and multi-drug resistance), gastrointestinal and respiratory infections, immunocompromised host infections, sexually transmitted and other infectious diseases. LiquidArray® technology supports next-generation multiplexing. ELITechGroup, acquired 2024, expanded Bruker's MDx portfolio by sample-to-answer platforms, positioning Bruker as an innovative and growing infectious disease specialist in the IVD market.

You can find our homepage here: www.bruker.com